LogicBio Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
LogicBio Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2022.
  • LogicBio Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was -$833K, a 140% decline year-over-year.
  • LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $3.24M, a 93.4% decline from 2020.
  • LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $48.7M, a 384% increase from 2019.
  • LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2019 was $10.1M, a 86.1% decline from 2018.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 -$833K -$2.92M -140% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q1 2021 $2.09M +$2.01M +2389% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $84K +$84K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.